UK MPs turn up the heat on medtech reg review with proposals to avert shopping for CE marks
This article was originally published in Clinica
Executive Summary
The UK’s House of Commons Science & Technology Committee (STC) has weighed into the medtech regulation debate with stricter pre- and post-market proposals than those put on the table by the EU Commission in its medical device directives revision texts.